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Implications for research
background: Recent systematic reviews of adjuvant acupuncture for IVF have pooled heterogeneous trials, without examining variables
that might explain the heterogeneity. The aims of our meta-analysis were to quantify the overall pooled effects of adjuvant acupuncture on IVF
clinical pregnancy success rates, and evaluate whether study design-, treatment- and population-related factors influence effect estimates.
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methods: We included randomized controlled trials that compared needle acupuncture administered within 1 day of embryo transfer, versus
sham acupuncture or no adjuvant treatment. Our primary outcome was clinical pregnancy rates. We obtained from all investigators additional
methodological details and outcome data not included in their original publications. We analysed sham-controlled and no adjuvant treatment-
controlled trials separately, but since there were no large or significant differences between these two subsets, we pooled all trials for subgroup
analyses. We prespecified 11 subgroup variables (5 clinical and 6 methodological) to investigate sources of heterogeneity, using single covariate
meta-regressions.
results: Sixteen trials (4021 participants) were included in the meta-analyses. There was no statistically significant difference between
acupuncture and controls when combining all trials [risk ratio (RR) 1.12, 95% confidence interval (CI), 0.96–1.31; I2 ¼ 68%; 16 trials; 4021 par-
ticipants], or when restricting to sham-controlled (RR 1.02, 0.83–1.26; I2 ¼ 66%; 7 trials; 2044 participants) or no adjuvant treatment-controlled
trials (RR 1.22, 0.97–1.52; I2 ¼ 67%; 9 trials; 1977 participants). The type of control used did not significantly explain the statistical heterogeneity
(interaction P ¼ 0.27). Baseline pregnancy rate, measured as the observed rate of clinical pregnancy in the control group of each trial, was a
statistically significant effect modifier (interaction P , 0.001), and this covariate explained most of the heterogeneity of the effects of adjuvant
acupuncture across all trials (adjusted R2 ¼ 93%; I2 residual ¼ 9%). Trials with lower control group rates of clinical pregnancy showed larger
effects of adjuvant acupuncture (RR 1.53, 1.28–1.84; 7 trials; 1732 participants) than trials with higher control group rates of clinical pregnancy
(RR 0.90, 0.80–1.01; 9 trials; 2289 participants). The asymmetric funnel plot showed a tendency for the intervention effects to be more beneficial
in smaller trials.
conclusions: We found no pooled benefit of adjuvant acupuncture for IVF. The subgroup finding of a benefit in trials with lower, but not
higher, baseline pregnancy rates (the only statistically significant subgroup finding in our earlier review) has been confirmed in this update, and was
not explained by any confounding variables evaluated. However, this baseline pregnancy rate subgroup finding among published trials requires
further confirmation and exploration in additional studies because of the multiple subgroup tests conducted, the risk of unidentified confounders,
the multiple different factors that determine baseline rates, and the possibility of publication bias.
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Introduction
Some 10–15% of couples have difficulty conceiving at some point in their
reproductive lives, and seek specialist fertility care (Evers, 2002). One of
the most commonly used treatment options is IVF and related expan-
sions of it [e.g. ICSI (ESHRE Capri Workshop Group, 2007)]. For the
year 2003, it was estimated that 932 000 IVF and related cycles were per-
formed worldwide, resulting in an estimated 232 000 babies being born
(Nygren et al., 2011). The USA has among the highest IVF success rates
worldwide, which is likely due to a combination of factors, including few
restrictions on the number of embryos that can be transferred and the
routine use of embryo selection (Abdalla, 2010; Nygren et al., 2011).
European countries generally have lower IVF success rates because
they are increasingly moving towards single embryo transfers (Gerris,
2005; Maheshwari et al., 2011) which carry lower health risks
(Pinborg, 2005); the rates of multiple births and the associated health
risks for mother and baby in Europe are approximately half of those in
the USA (Nygren et al., 2011).
Despite many recent technological advances, average success rates
with IVF remain low, with only 30% of treatment cycles resulting in a
live birth in the USA (Centers for Disease Control and Prevention,
2011). Consequently, there is a need to investigate new laboratory tech-
niques and drug therapies to improve the success rates of IVF, by means
other than increasing the number of embryos transferred. However,
progress in developing such safe and effective therapies has been
limited (Harper et al., 2012), driving patients to consider IVF adjuvant
complementary and alternative medical (CAM) therapies (Smith et al.,
2010), many of which are unproved and inadequately investigated. Acu-
puncture is the most commonly used adjuvant CAM fertility treatment
among couples seeking fertility care in US fertility clinics (Smith et al.,
2010; Domar et al., 2012). ‘Fertility problems’ is the second most
common health condition, following pain-related conditions, for which
people seek acupuncture treatment in the UK (Hopton et al., 2012).
A review of the effects of adjuvant acupuncture on IVF is warranted
because acupuncture has been found to be relatively safe among
general patient populations (Witt et al., 2011) and also among women
at various stages of pregnancy (Smith et al., 2002; Kvorning et al.,
2004; Elden et al., 2005), it is low cost, and, if effective in increasing IVF
success rates, could potentially reduce the need for an additional high
cost IVF cycle. Furthermore, qualitative research suggests that adjuvant
acupuncture may help IVF patients deal with the psychological and emo-
tional issues that accompany both subfertility and IVF treatment (de
Lacey et al., 2009; Kovarova et al., 2010; Smith et al., 2011; Isoyama
et al., 2012).
We updated our previous systematic review and meta-analysis
(Manheimer et al., 2008) with nine new trials including 2672 new rando-
mized participants, and carried out an a priori defined set of subgroup
analyses to evaluate whether estimates of the effects of adjuvant acu-
puncture on IVF success rates is influenced by study design-, treatment-
and population-related factors.
Methods
The systematic review protocol was registered in the PROSPERO database
of prospectively registered systematic reviews (identification number:
CRD42011001309) in May 2011 (Manheimer et al., 2011). The systematic
review follows PRISMA reporting guidelines (Moher et al., 2009).
Identification of studies
We searched Medline (OVID), Embase (Elsevier Sciences), CENTRAL
(2012, Issue 4) (OVID), and the Chinese databases Sino-Med (previously
called the Chinese Biomedical Database), Chinese National Knowledge















Infrastructure, and VIP Database for Chinese Technical Periodicals, from in-
ception to April 2012 (the MEDLINE search strategy is available from the
author). We also searched the proceedings of the following three major
annual conferences on assisted reproductive technology for 2001–2012:
American Society for Reproductive Medicine; European Society of Human
Reproduction and Embryology; and Pacific Coast Reproductive Society.
We also searched for previous systematic reviews on this topic, and reviewed
their reference lists (Cheong et al., 2008, 2010; El-Toukhy et al., 2008; Man-
heimer et al., 2008; Ng et al., 2008; El-Toukhyand Khalaf, 2009; Sunkara et al.,
2009; Qu et al., 2012; Zheng et al., 2012a, b). In addition, we sent the provi-
sional list of included and excluded trials to experts in the field (see Acknowl-
edgements), and asked if they were aware of any potentially eligible trials,
published or unpublished, that were not on our list. To identify trials that
may be relevant for future updates of this review, we also searched the fol-
lowing databases of ongoing trials: the US National Institutes of Health’s clin-
icaltrials.gov, the World Health Organization’s International Clinical Trials
Registry Platform, and controlled-trials.com.
Selection criteria, data extraction
and quality assessment
We sought randomized controlled trials (RCTs) that compared acupuncture
with sham acupuncture or no adjuvant treatment. Because we evaluated acu-
puncture as a complement to embryo transfer, we considered only RCTs in
which acupuncture was administered within 1 day of the procedure, with the
objective of improving IVF success rates. Trials that included ICSI as part of
the IVF procedure were eligible.
We excluded RCTs which evaluated electrical acupuncture as an alterna-
tive to conventional anaesthesia for the surgical procedure of removing the
oocytes from the woman’s ovaries. We considered these two sets of
RCTs to be fundamentally different, in terms of the aim of the treatment
with acupuncture, the timing of acupuncture administration (i.e. during
oocyte retrieval versus embryo transfer) and the acupuncture protocol
used. That is, when acupuncture is used during oocyte retrieval, the
primary purpose is to relieve pain, and correspondingly, electrical stimulation
of the needles is always used (Ulett et al., 1998) and the points are selected to
effect pain reduction. In contrast, when acupuncture is used to accompany
embryo transfer, the primary purpose is to assist conception, electrical stimu-
lation of the needles may or may not be used, and the points are selected to
improve blood flow to the uterus to make it more receptive to the embryo
(Stener-Victorin et al., 1996). In addition, two systematic reviews (Kwan
et al., 2013; Stener-Victorin, 2005) have already evaluated electroacupunc-
ture as an alternative to anaesthesia during oocyte retrieval, and pooled
analyses found no statistically significant differences in later pregnancy rates
between the electroacupuncture and conventional anaesthesia groups.
We included only trials in which acupuncture involved the insertion of
needles into traditional meridian points. The needles could be inserted
into tender points in addition to the traditional meridian points, and the
needles could also be electrically stimulated.
We included RCTs in any language, published as either full articles or
abstracts. We also included any unpublished trials that we identified, but
only if we were able to obtain sufficient and reliable information on their
methods and outcomes.
For trials to be eligible, we had to be able to extract data on at least one of
the following outcomes, as recommended (Daya, 2003; Griesinger et al.,
2004; Arce et al., 2005): clinical pregnancy [i.e. presence of at least one ges-
tational sac or fetal heartbeat, confirmed by transvaginal ultrasound
(Zegers-Hochschild et al., 2006)], ongoing pregnancy (i.e. pregnancy
beyond 12 weeks of gestation, as confirmed by fetal heart activity on ultra-
sound) or live birth.
Two authors independently selected articles and extracted data, with dis-
agreements resolved by discussion. We extracted data pertaining to the
quality of the methods, participants, interventions and outcomes. We con-
tacted corresponding authors with specific questions related to the design
and outcomes of their trials and asked them to review the information we
extracted from their trials and clarify any ambiguities.
We evaluated the methodological quality of the trials using the Cochrane
risk of bias tool (Higgins and Altman, 2011), supplemented with an additional
item that assessed whether there was a co-intervention that was applied un-
equally across treatment groups. We added ‘unequal co-intervention’ to the
Cochrane tool because this item can indicate an important source of bias and
has been included in other quality assessment tools (van Tulder et al., 2003),
including an assessment tool used in subfertility meta-analyses (Cochrane
Menstrual Disorders and Subfertility Group, 2010).
Data synthesis and analysis
The pooled risk ratio (RR) of achieving a clinical pregnancy for women in
the acupuncture group compared with women in the control group was
the primary outcome measure. We prespecified clinical pregnancy instead
of live birth as our primary outcome because it would allow for more
RCTs and more data to contribute to our primary analyses, as only 22% of
subfertility RCTs that report the clinical pregnancy outcome data also
report the live birth outcome data (Clarke et al., 2010). Therefore, including
clinical pregnancy as the primary outcome will avoid the risk of including in the
primary analysis only a subset of the RCTs (i.e. only those RCTs that report
live births), which may not be representative of all RCTs included in the
review (Manheimer et al., 2008). In addition, clinical pregnancy is a practical
and clinically relevant surrogate for live birth because 84% of clinical
pregnancies achieved through IVF would be expected to result in a live
birth, based on data from IVF RCTs (Clarke et al., 2010). Also, the effect
estimates on the clinical pregnancy outcome have been shown to be nearly
identical to the effect estimates on the live birth outcome for IVF RCTs
that report both outcomes [i.e. ratio of odds ratios: 0.99 (95% confidence
interval (CI), 0.87–1.13)] (Clarke et al., 2010). Finally, the clinical pregnancy
outcome may allow for easier control of potentially confounding factors,
which might be introduced after the first trimester, once the women are
no longer under the care of the IVF clinic. That is, collecting reliable informa-
tion about live births after patients have left the IVF clinic might be difficult
because patients, who may travel long distances to reach the clinic, might
be less accessible to the clinic staff after the clinical pregnancy is achieved
(Daya, 2003; Arce et al., 2005; Clarke et al., 2010). Ongoing pregnancy,
live birth and spontaneous abortion rates were analysed as secondary
outcomes.
For pooled data, summary test statistics were calculated using the
DerSimonian and Laird model (DerSimonian and Laird, 1986; Deeks and
Higgins, 2010), which is the random effects model used in the RevMan soft-
ware, version 5.1 (The Nordic Cochrane Centre. The Cochrane Collabor-
ation, 2011). This model estimates the average treatment effect by
incorporating heterogeneity among clinically diverse trials with different,
but related, treatment effects. When heterogeneity exists, the model
assigns smaller studies more weight than they would receive in a fixed
effects model (Deeks et al., 2011). We used the random effects model
because of the expected heterogeneity of the studies’ acupuncture protocols
and settings. We evaluated heterogeneity using both the I2 statistic, which
indicates the proportion of variability across trials not explained by sampling
variation alone, and the P-value of the x2 test of heterogeneity (Deeks et al.,
2011). Although interpreting the importance of inconsistency depends on
other factors in addition to the I2 values (e.g. P-value from x2 test, magnitude
and direction of effects), the Cochrane Handbook suggests the following
rough guide to interpreting I2 values: ‘0–40% might not be important; 30–
60% may represent moderate heterogeneity; 50–90% may represent sub-
stantial heterogeneity; and 75–100% may represent considerable hetero-
geneity’ (Deeks et al., 2011).















We included in the meta-analyses all randomized women who began the
IVF process including those who did not complete the treatment (i.e. had no
embryo transfer), even if these participants were excluded in the author’s
analysis of the trial. Although inclusion of women without an embryo transfer
will tend to underestimate the effect of acupuncture (Daya, 2003), it is the
more conservative and appropriate analytical approach (Daya, 2003; Grie-
singer et al., 2004; Deeks et al., 2006; Dias et al., 2006) because it preserves
the groups created by the randomization and reduces the chance of a type I
error (Daya, 2003). The only randomized participants we did not include
were those for whom the clinical pregnancy or live birth outcome data
were missing.
We analysed the sham-controlled and no adjuvant treatment-controlled
trials separately, but if there was no large or significant difference in pooled
effect estimates between these two subgroups of trials, we pooled all avail-
able trials.
If at least 10 trials were available for a meta-analysis, we assessed for the
likelihood of publication bias by constructing funnel plots (Sterne et al., 2011).
Subgroup analyses
We conducted subgroup analyses on five clinical characteristics that might in-
fluence the effect of adjuvant acupuncture on clinical pregnancy success rates:
(i) two acupuncture sessions or more than two; (ii) selection of meridian acu-
puncture points the same as the points selected in the first published trial
(Paulus et al., 2002) that evaluated acupuncture as an adjuvant to embryo
transfer, and which showed a large effect, or a modified version of this
trial’s acupuncture point selection protocol; (iii) control group clinical preg-
nancy rate (as an estimate of the baseline clinical pregnancy rate) dichoto-
mized as higher [32% or greater, which is the European average of
pregnancy rate per embryo transfer (de Mouzon et al., 2012)] or lower;
the control group clinical pregnancy rate was also analysed as a continuous
variable to test whether the relation was linear and consistent with the find-
ings of the categorical analysis; (iv) explanatory trials conducted to test the
effects of adjuvant acupuncture under controlled conditions in which the acu-
puncture was administered onsite at the IVF clinic or pragmatic trials con-
ducted to test the effects of adjuvant acupuncture delivered off-site, which
might better approximate every day, ‘real life’ conditions since most IVF
clinics do not have onsite acupuncturists (Arce et al., 2005); and (v) trials
that involved a treating acupuncturist who was judged as adequately experi-
enced or not adequately experienced, with such judgments made by acu-
puncturist assessors who were blinded to the identities and results of the
trials.
In addition, to assess whether the effects varied with the risk of bias
domains of the trials, we also conducted subgroup analyses (Deeks et al.,
2011) on the following six ‘risk of bias’ domains: random allocation sequence
generation; concealment of allocation of randomization sequence; blinding of
patients (i.e. use of sham control); blinding of embryo transfer physicians; in-
complete outcome data; and unequal co-intervention.
For each subgroup analysis, we performed a single covariate weighted
random effects meta-regression (Thompson and Higgins, 2002; Knapp and
Hartung, 2003; Higgins and Thompson, 2004) in Stataversion 11 (StataCorp)
(Harbord and Higgins, 2008) to investigate whether differences in effects of
adjuvant acupuncture between the covariate’s two subgroups were statistic-
ally significant. In interpreting the importance of subgroup effects, we also
considered the difference in the magnitude or direction of effect between
the two subgroups as well as whether or not the CIs of the subgroups over-
lapped (Deeks et al., 2011). For each single covariate meta-regression sub-
group analysis, we calculated the P-value of the test for interaction; the
percentage of the between-study variance explained by the covariate
(adjusted R2); and the percentage of the residual variation that is attributable
to between-study heterogeneity (I2res). A random effects meta-regression
model was used rather than a fixed effects model or univariate subgroup
testing because the random effects meta-regression model allows for poten-
tial residual heterogeneity and it is therefore a more conservative analytical
approach. We did not attempt to develop a multivariate meta-regression
model, primarily because of the relatively small number of studies relative
to the number of subgroup variables prespecified, but also because our ob-
jective was to identify modifiers of the effects of adjuvant acupuncture on IVF,
rather than to build an optimal ‘prediction’ model. A major limitation of sub-
group analyses is the potential bias by confounding (Thompson and Higgins,
2002). Therefore, we also examined whether the apparent effect modifica-
tion due to a specific subgroup variable might be explained by an association
between that subgroup variable of interest and a potentially confounding sub-
group variable, by including both variables in a meta-regression model.
Sensitivity analyses
For our primary analyses, we excluded participants with unrecorded clinical
pregnancy data; however, for sensitivity analyses, we imputed the rate of clin-
ical pregnancies in participants with unrecorded outcomes using available
case rates: (i) from the corresponding trial group that these participants
were assigned to (i.e. either acupuncture or control); and (ii) from the corre-
sponding trial’s acupuncture plus control group combined. We also con-
ducted a third sensitivity analysis which assumed that no randomized
participants with an unrecorded outcome achieved a clinical pregnancy.
Results
Supplementary data, Fig. S1 shows the study selection process. The list of
studies that were excluded with the reasons for exclusion and the list of
characteristics of the ongoing trials are available from the author.
Sixteen RCTs with a total of 4038 participants met the inclusion cri-
teria (Table I; full details of the trials are available from the author). All
trials were published in English since 2002, and were conducted in
seven different countries. Ten were published as full reports (Paulus
et al., 2002; Dieterle et al., 2006; Smith et al., 2006; Westergaard
et al., 2006; Domar et al., 2009; So et al., 2009, 2010; Andersen et al.,
2010; Madaschi et al., 2010; Moy et al., 2011) and six were published
as abstracts (Paulus et al., 2003; Craig et al., 2007; Fratterelli et al.,
2008; Arnoldi et al., 2010; Omodei et al., 2010; Feliciani et al., 2011).
We obtained unpublished methodological information for all trials, and
unpublished live birth outcome data for seven trials (Paulus et al.,
2002, 2003; Dieterle et al., 2006; Westergaard et al., 2006; Craig
et al., 2007; Arnoldi et al., 2010; Omodei et al., 2010).
Trial characteristics
The only differences in trial eligibility criteria were that: two German trials
(Paulus et al., 2002, 2003) included only women with good-quality
embryos whereas the other trials included women with embryos of
varying quality; one trial (Arnoldi et al., 2010) restricted eligibility to
women with an unfavourable reproductive prognosis; one trial (So
et al., 2010) restricted eligibility to frozen–thawed embryo transfer
cycles while the others used fresh embryos; and one trial (Madaschi
et al., 2010) used ICSI for all participants, whereas all other trials reported
use of ICSI for only some participants.
The timing of the acupuncture sessions relative to embryo transfer dif-
fered somewhat among trials (Table I). In all trials, however, women
received acupuncture on the day of embryo transfer, before and/or
after the embryo transfer procedure. In all but one trial (Craig et al.,
2007), the acupuncture was administered directly on-site of the IVF
clinic. The number of acupuncture treatments ranged from one to
















Table I Characteristics of included trials.
Study, Country (reference) na Acupuncture Control typeb
Andersen, Denmark (Andersen et al.,
2010)
635 Two sessions: (1) 30 m before ET; (2) immediately after ET.
[To maintain blinding, needles not manipulated to obtain
de qi needling sensation]; (n ¼ 314.)
Non-penetrating blunt needles, placed on the
real acupoints [and not manipulated to achieve
de qi sensation]; (n ¼ 321)
Arnoldi, Italy (Arnoldi et al., 2010) 204 Three sessions: (1) d 5 of ovarian stimulation; (2) 30 m before
ET; (3) immediately after ET. [Needles stimulated manually by
rotating, lifting and thrusting the handle of the needle in order to
maintain de qi sensation, both during initial insertion and after
10 m]; (n ¼ 102.)
No adjuvant treatment (n ¼ 102)
Craig, USA (Craig et al., 2007) [113] Two sessions, both at an off-site location: (1) within 1–2 h
before ET; (2) within 1–2 h after ET. [Needles simulated
manually at insertion, and then manually rotated after 10 m to
maintain de qi]; (n ¼ 57.)
No adjuvant treatment (n ¼ 56)
Dieterle, Germany (Dieterle et al.,
2006)
225 Two sessions: (1) immediately after ET; (2) 3 days after ET.
Needles rotated at the start and after 15 m, to evoke de qi
(n ¼ 116)
Needle acupuncture, with needles inserted in
real acupoints not expected to influence
fertility (n ¼ 109)c
Domar, USA (Domar et al., 2009) 150 Two sessions: (1) 25 m before ET; (2) immediately after ET
(n ¼ 78)d
No adjuvant treatment (n ¼ 68)
Feliciani, Italy (Feliciani et al., 2011) 46 Three sessions: (1) 5–7 d before egg retrieval; (2) 2–3 d before
oocyte retrieval; (3) within 1 h after ET. [Needles manipulated
to obtain de qi]; (n ¼ 23.)
No adjuvant treatment (n ¼ 23)
Fratterelli, USA (Fratterelli et al.,
2008)
397 Two sessions: (1) 25 m before ET; (2) after ET (n ¼ 200)d No adjuvant treatment (n ¼ 197)e
Madaschi, Brazil (Madaschi et al.,
2010)
[455]f Two sessions: (1) 25 m before ET; (2) immediately after ET.
Needles manipulated until de qi sensation obtained (n ¼ 230)
No adjuvant treatment (n ¼ 225)
Moy, USA (Moy et al., 2011) 161 Two sessions: (1) 25 m before ET; (2) immediately after ET.
[Needles rotated to obtain de qi sensation]; (n ¼ 87.)
Needle acupuncture, with body acupuncture
insertion sites close to, but not on, the real
acupoints, with same manipulation of needles,
as performed in true acupuncture group
(n ¼ 74)
Omodei, Italy (Omodei et al., 2010) 168 Two sessions: (1) 25 m before ET; (2) immediately after ET
(n ¼ 44)d
No adjuvant treatment (n ¼ 124)
Paulus, Germany (Paulus et al., 2002) 160 Two sessions: (1) 25 m before ET; (2) immediately after ET.
Needles rotated at the start and after 10 m, to evoke de qi
(n ¼ 80)
No adjuvant treatment (n ¼ 80)
Paulus, Germany (Paulus et al., 2003) 200 Two sessions: (1) 25 m before ET; (2) immediately after ET.
Needles rotated after 10 m to evoke de qi (n ¼ 100)
Non-penetrating blunt needles, placed on the
real acupoints (n ¼ 100)c
Smith, Australia (Smith et al., 2006) 228 Three sessions: (1) d 9 of stimulating injections; (2) 25 m before
ET; (3) immediately after ET. [Needles manually stimulated to
obtain de qi sensation]; (n ¼ 110.)
Non-penetrating blunt needles, placed close
to, but not on, the real acupoints, with the sham
needles manipulated by lifting and thrusting the
handle of the needles and running a fingernail
along the handle, but de qi not sought
(n ¼ 118)
So, Hong Kong/China (So et al., 2009) 370 Two sessions: (1) 25 m before ET; (2) immediately after ET.
Needles stimulated manually by rotating, lifting and thrusting the
handle of the needle in order to maintain de qi sensation, both
during initial insertion and after 10 m (n ¼ 185)
Non-penetrating blunt needles, placed on the
real acupoints, and manipulated in the same
way as the true acupuncture needles to give
patients a pricking, penetrating sensation
(n ¼ 185)
So, Hong Kong/China (So et al., 2010) 226 One session immediately after ET. Needles stimulated manually
by rotating, lifting and thrusting the handle of the needle in order
to maintain de qi sensation, both during initial insertion and after
10 m (n ¼ 113)
Non-penetrating blunt needles, placed on the
real acupoints, and manipulated in the same
way as the true acupuncture needles to give
patients a pricking, penetrating sensation
(n ¼ 113)
Continued















three. In all trials, the acupuncture sessions lasted 25–30 min. In all trials,
the acupuncture protocol and selection of acupuncture points was
designed for the sole purpose of improving rates of pregnancy.
Twelve trials reported that the ‘de qi’ needling sensation (i.e. a pain,
achiness, stinging or dullness at the needle insertion site, which is an
indicator that the acupuncture needle has been correctly placed)
was sought (Paulus et al., 2002, 2003; Dieterle et al., 2006; Smith
et al., 2006; Westergaard et al., 2006; Craig et al., 2007; So et al.,
2009, 2010; Arnoldi et al., 2010; Madaschi et al., 2010; Feliciani
et al., 2011; Moy et al., 2011), whereas one sham-controlled trial
reported that there was no attempt to manipulate the needles to
achieve the ‘de qi’ needling sensation, in order to avoid unblinding
trial participants (Andersen et al., 2010). The three other trials did
not report on de qi (Fratterelli et al., 2008; Domar et al., 2009;
Omodei et al., 2010). No trial used electroacupuncture. For all trials,
the mean numbers of embryos transferred was similar between the
randomized groups.
Methodological quality of included trials
A summary of the risks of bias is presented in Table II; full details of the
quality assessments are available from the authors. For one trial
(Madaschi et al., 2010), the method of generating the random allocation
sequence was not clear; however, the randomization appeared to be
successful in creating similar groups, as there were no baseline differ-
ences in prognostic factors between treatment groups. For the other
15 trials, adequate methods of sequence generation were used. For
three trials (Arnoldi et al., 2010; Madaschi et al., 2010; Feliciani et al.,
2011), there was inadequate allocation concealment (Table II), but in
these trials there was also baseline similarity between the two groups.
In three trials (Westergaard et al., 2006; Craig et al., 2007; Moy et al.,
2011), there were small numbers of randomized women with missing
clinical pregnancy outcomes (Fig. 1, footnotes). In four trials (Smith
et al., 2006; Westergaard et al., 2006; Craig et al., 2007; Madaschi
et al., 2010), some randomized women began the IVF process but did
not complete the treatment (that is, no embryo transfer); however, as
noted above, these women were still included in the meta-analyses.
Seven of the trials used a sham acupuncture control (Paulus et al.,
2003; Dieterle et al., 2006; Smith et al., 2006; So et al., 2009, 2010;
Andersen et al., 2010; Moy et al., 2011), of which four (Paulus et al.,
2003; So et al., 2009, 2010; Andersen et al., 2010) used the Streitberger
non-penetrating sham needles (Streitberger and Kleinhenz, 1998; White
et al., 2003) placed on the true acupuncture points (Table I). The remain-
ing nine trials used a no adjuvant treatment control. For 10 trials, the
embryo transfer physicians were blinded to the treatment assignments
(Paulus et al., 2002, 2003; Dieterle et al., 2006; Craig et al., 2007;
Domar et al., 2009; So et al., 2009, 2010; Andersen et al., 2010; Madaschi
et al., 2010; Moy et al., 2011); for the other six trials the physicians were
not blinded (Smith et al., 2006; Westergaard et al., 2006; Fratterelli et al.,
2008; Arnoldi et al., 2010; Omodei et al., 2010; Feliciani et al., 2011;
Table II).
Efficacy analysis
There were no statistically significant pooled benefits of adjuvant acu-
puncture relative to either control, for the clinical pregnancy, ongoing
pregnancy or live birth outcomes; however, the overall statistical hetero-
geneity was substantial for each outcome (I2 ¼ 68, 69 and 68%; x2
P-value ¼ 0.0001, 0.0004 and 0.0003, respectively; Fig. 1). The type of
control used did not significantly explain this statistical heterogeneity
(interaction P ¼ 0.27, for clinical pregnancy outcome; Fig. 1).
Of the 11 variables planned for subgroup analyses for the clinical preg-
nancy outcome, only 10 could be tested because no trial had a high risk of
bias from incomplete outcome data. In addition, only the Craig et al.
(2007) trial used an ‘unequal co-intervention’, which was driving to
and from the off-site acupuncturist’s office, before and after the
embryo transfer procedure, in only the acupuncture group. Therefore,
the ‘unequal co-intervention’ and ‘site of acupuncture administration’
variables classified trials in the same subgroups, and therefore had the
same subgroup effect results.
We combined all 16 trials for the meta-regression subgroup analyses.
Of the 10 subgroup variables tested, only baseline clinical pregnancy rate
was a statistically significant effect modifier of adjuvant acupuncture
(Fig. 2). Baseline pregnancy rate was also the only variable tested that
explained a large proportion of the between-study variance. That is, in
the meta-regression model fit with the single covariate of baseline clinical
pregnancy rate, the adjusted R2 ¼ 90% when baseline clinical pregnancy
rate was operationalized as a continuous variable (interaction P , 0.001)
.............................................................................................................................................................................................
Table I Continued
Study, Country (reference) na Acupuncture Control typeb
Westergaard, Denmark
(Westergaard et al., 2006)
300 Acupuncture group 1: (1) 25 m before ET; (2) immediately after
ET (n ¼ 100); Acupuncture group 2: (1) 25 m before ET; (2)
immediately after ET; (3) 2 d after ET. Needles rotated at the
start and after 10 m, to evoke de qi (n ¼ 100)g
No adjuvant treatment (n ¼ 100)
Additional data obtained from RCT authors are enclosed in brackets to allow such data to be differentiated from the data included only in the publications. Acupoints, Acupuncture points;
d, day; ET, embryo transfer; h, hour; m, minute.
aNumber randomized.
bFor all sham-controlled trials, the sham acupuncture procedure was given on the same schedule as that used for the true acupuncture group.
cThese two trials did not report whether the sham needles were manipulated in the same way as the true acupuncture needles.
dThese three trials did not report whether or not the needles used in the true acupuncture group were manipulated to achieve the de qi sensation.
eWe excluded from our meta-analysis the following three additional control groups included in this trial: laser acupuncture, sham laser acupuncture and relaxation.
fThe 39 participants (22 acupuncture; 17 control) who did not proceed to embryo transfer were excluded from the trial authors’ analysis. The approach for our meta-analysis was to
re-include these participants [i.e. acupuncture group ¼ 230 (i.e. 208 + 22) and the no acupuncture group ¼ 225 (i.e. 208 + 17)], because it could be assumed that these participants
without an embryo transfer did not achieve the clinical pregnancy outcome.
gFor this trial, acupuncture groups 1 and 2 were combined together for the meta-analysis.















and the adjusted R2 ¼ 93% when the baseline pregnancy rate was oper-
ationalized as a dichotomous variable (interaction P , 0.001). To evalu-
ate whether any of the other prespecified subgroup variables was a
confounder of the effects of baseline pregnancy on IVF clinical pregnancy
success rates, we also fit nine other separate meta-regression models
which included both baseline pregnancy rate as a continuous variable
and one of each of the nine other prespecified subgroup variables. In
none of these nine other models did the correlation coefficient of the
baseline clinical pregnancy rate variable substantially change (i.e. the
maximum percentage change of the coefficient was 7%). To investigate
whether the effect modification of baseline pregnancy rate was
maintained across trial subsets, we also fit six separate single covariate
(i.e. baseline pregnancy rate) meta-regression models, restricting to
subsets of trials, according to type of control (sham or no adjuvant treat-
ment), blinding of embryo transfer physician (yes or no) and allocation
concealment (yes or no). In these meta-regression models, the magni-
tude of the baseline pregnancy rate subgroup effect was maintained
when restricting to: sham-controlled trials [76% difference in RR esti-
mates between sham-controlled trials with higher (RR ¼ 0.89), com-
pared with sham-controlled trials with lower (RR ¼ 1.65), baseline
pregnancy rates; interaction P ¼ 0.022; adjusted R2 ¼ 100%); no adju-
vant treatment-controlled trials (63% difference in RR; P ¼ 0.012;
.............................................................................................................................................................................................
Table II Risk of bias summary of included trials.




















(Andersen et al., 2010)
Low risk [Low risk] Low risk Low risk Low risk Low risk Low risk
Arnoldi, Italy (Arnoldi et al., 2010) Low risk [High risk]a High risk [High risk] [Low risk]b Low risk Low risk
Craig, USA (Craig et al., 2007) [Low risk] [Low risk] High risk Low risk [Low risk] Low risk High risk
Dieterle, Germany
(Dieterle et al., 2006)
[Low risk] [Low risk] Low risk Low risk Low risk Low risk Low risk
Domar, USA (Domar et al., 2009) Low risk [Low risk] High risk [Low risk] [Low risk]c Low risk Low risk
Feliciani, Italy (Feliciani et al., 2011) [Low risk] [High risk] High risk [High risk] [Low risk] Low risk Low risk
Fratterelli, USA (Fratterelli et al.,
2008)
Low risk Low risk High risk High risk Low risk Low risk Low risk
Madaschi, Brazil (Madaschi et al.,
2010)
[Unclear]d [High risk]e High risk [Low risk] [Low risk]f Low risk Low risk
Moy, USA (Moy et al., 2011) Low risk Low risk Low risk Low risk Low risk Low risk Low risk
Omodei, Italy (Omodei et al., 2010) [Low risk] [Low risk] High risk [High risk] [Low risk] Low risk Low risk
Paulus, Germany (Paulus et al., 2002) Low risk [Low risk] High risk Low risk [Low risk] Low risk Low risk
Paulus, Germany (Paulus et al., 2003) [Low risk] [Low risk] Low risk [Low risk] [Low risk] Low risk Low risk
Smith, Australia (Smith et al., 2006) [Low risk] [Low risk] Low risk [High risk] [Low risk] Low risk Low risk
So, Hong Kong/China (So et al., 2009) Low risk Low risk Low risk Low risk Low risk Low risk Low risk
So, Hong Kong/China (So et al., 2010) Low risk Low risk Low risk Low risk Low risk Low risk Low risk
Westergaard, Denmark
(Westergaard et al., 2006)
[Low risk] [Low risk]g High risk High risk [Low risk] Low risk Low risk
Additional data obtained from RCT authors are enclosed in brackets to allow such data to be differentiated from data included only in the publications.
aAlthough sealed envelopes were used, the envelopes were not sequentially numbered and the trial’s investigators could not recall whether or not the envelopes were opaque.
bAlthough there was a large imbalance in the number of women who did not proceed to an embryo transfer (i.e. 6/102 in acupuncture group and 20/102 in control group), which the trial
authors postulated to be due to the acupuncture increasing the likelihood of a viable embryo being available for transfer, the outcomes for the randomized participants without embryo
transfer were known (i.e. not pregnant), so we did not consider this as a bias due to incomplete outcome data.
cThe treatment assignment and the outcomes for 4/150 randomized participants were not recorded by the trial authors. Therefore, the 146 participants analysed were instead used in the
authors’ analysis (Domar et al., 2009), and for this meta-analysis. However, we scored this criterion as ‘low risk’ for incomplete outcome data because the reasons for missing outcome data
were unlikely to be related to the outcomes and the proportion of missing outcomes was not likely to have a clinically relevant impact on the effect estimates (Higgins and Altman, 2011).
dA computer-generated randomization list was used to assign patients to treatment groups. However, this trial was judged as unclear for ‘allocation sequence generation’ because it was not
clear how the trial authors assigned to treatment groups 39 new participants who replaced the 39 participants excluded because of no embryo transfer.
eThis trial used an open randomization list, so the investigators enrolling participants could possibly foresee assignments and thus introduce selection bias.
fIn this trial, the randomization occurred prior to the start of the ovarian stimulation, although the participants were not informed of their treatment assignment until the start of the ovarian
stimulation. Approximately 15% of participants were randomized, but then decided not to get IVF, primarily because of its costs and withdrew prior to the start of the ovarian stimulation.
Because these participants withdrew from the study before they were told whether they had been randomized to acupuncture or control, their decision to withdraw from the trial could not
have been affected by knowledge of the randomized intervention (i.e. acupuncture or control), and these withdrawals would not be expected to cause an important bias due to missing
outcome data (Higgins and Altman, 2011).
gFor this trial, the randomization treatment assignments were placed in sealed, opaque envelopes, which were shuffled and deposited in a cardboard box, from which each participant
selected only one. This procedure has handled by an independent nurse not responsible for obtaining information about patients and enrolling them. Although the envelopes were not
sequentially numbered, we considered the safeguards used in the randomization process to have provided adequate assurance of allocation concealment.















Figure 1 Effects of acupuncture on clinical pregnancy, ongoing pregnancy and live birth outcomes. The centres of the squares represent estimates from
individual trials, the centres of the quadrilaterals represent pooled estimates and the horizontal lines represent 95% CIs.















adjusted R2 ¼ 79%); trials with embryo transfer blinding (60% difference
in RR; P ¼ 0.005; adjusted R2 ¼ 92%); trials without embryo transfer
blinding (59% difference in RR; P ¼ 0.039; adjusted R2 ¼ 100%); trials
with adequate allocation concealment (76% difference in RR; P ,
0.001; adjusted R2 ¼ 98%); and trials without adequate allocation con-
cealment (40% difference in RR; P ¼ 0.661; adjusted R2 could not be
calculated because only three trials were included in this meta-regression
model).
Figure 3 shows a graph of the meta-regression line, fit with the single
continuous covariate of baseline pregnancy rate. This meta-regression
model showed that a 20 and 40% increase in baseline pregnancy rate
was associated, respectively, with a 33 and 55% decrease in the RR of
clinical pregnancy with adjuvant acupuncture. A 20 and 40% decrease
in baseline clinical pregnancy rate was associated, respectively, with a
49 and 122% increase in the RR of clinical pregnancy.
The subgroup variables ‘blinding of embryo transfer physician’ and
‘site of acupuncture administration’ were borderline statistically signifi-
cant across all trials (interaction P ¼ 0.084 and 0.096, respectively);
however, neither variable explained a large proportion of the
between trial variability (adjusted R2 ¼ 22 and 19%, respectively).
Because the trials that blinded the embryo transfer physician also
tended to blind the patients (i.e. use a sham control; see Table II),
we were concerned about confounding between these two variables.
Therefore, we also fit a meta-regression model which included the
patient blinding variable in addition to the embryo transfer physician
blinding variable. In this model which included both variables, the
correlation coefficient of the embryo transfer physician blinding vari-
able was not substantially changed (i.e. from 20.158 to 20.150),
and the interaction P-value of the embryo transfer blinding covariate
only increased slightly (i.e. from P ¼ 0.084 to P ¼ 0.15). Finally,
because the only trial that evaluated acupuncture administered
off-site of the IVF clinic (Craig et al., 2007) used a no adjuvant treat-
ment control, we also fit a meta-regression model using the single cov-
ariate of site of acupuncture administration, but restricting to the no
adjuvant treatment-controlled trial subset. In this meta-regression
model, the site of acupuncture administration covariate was statistic-
ally significant (interaction P ¼ 0.04), and this covariate explained
some of the heterogeneity within this subset of trials (adjusted R2 ¼
61%). The embryo transfer blinding variable was not a statistically
significant effect modifier when restricting to the sham-controlled
(interaction P ¼ 0.476) or no adjuvant treatment-controlled (P ¼
0.246) trial subsets. Although we initially planned subgroup analyses
stratified by control type, we combined all trials for our final subgroup
analyses shown in Fig. 2 because of the largely similar subgroup effects
across the two control groups.
The funnel plot (Fig. 4) showed small study effects, with the interven-
tion effects estimated in smaller studies showing more benefit than the
effects estimated in larger studies. The Egger statistical test for funnel
plot asymmetry found that the association between estimated interven-
tion effects and the standard error of the intervention effect (as a
measure of the trial’s size) was greater than would be expected to
occur by chance (P ¼ 0.032).
Figure 1 Continued.
















The use of the different methods of imputing the unrecorded
outcome data values did not affect the results of the individual
trials, any of the pooled results or the results of any of the subgroup
analyses. In trials that had participants with unrecorded clinical preg-
nancy outcomes (Westergaard et al., 2006; Craig et al., 2007;
Moy et al., 2011), imputing these values using available case rates
from the corresponding trial group that these participants were
assigned to resulted in very similar pooled estimates for the primary
outcome measure (RR ¼ 1.12; 95% CI, 0.96–1.30; I2 ¼ 68%; 16
trials). Imputing the values using the corresponding trial’s acupuncture
plus control group combined resulted in identical pooled estimates.
Assuming that no participants with an unrecorded outcome achieved
a clinical pregnancy resulted in very similar pooled estimates (RR ¼
1.13; 95% CI, 0.96–1.31; I2 ¼ 69%; 16 trials).
Safety of acupuncture
Figure 5 shows the spontaneous abortion rates calculated as the number
of losses between clinical pregnancy and live birth divided by the number
of clinical pregnancies. Similar results were obtained when calculating
Figure 2 Meta-regression subgroup analyses for the primary outcome (i.e. clinical pregnancy). The quadrilaterals represent pooled estimates from the
trials included in the given subgroup. The estimated regression coefficient from each model was obtained by a weighted least squares meta-regression with
RR of pregnancy as the dependent variable, using the modification to the variance of the estimated coefficient suggested by Knapp and Hartung (2003), and
supported by Higgins and Thompson (2004). I2resid values indicate the proportion of the residual variation that is attributable to between-study heterogen-
eity. The adjusted R2 values indicate the proportion of between-study variance explained by the covariate. The P-values for test of interaction indicate
whether the observed differences in results of trials within a given subgroup are compatible with chance alone. *The So 2010 trial was the only trial that
used only one acupuncture treatment session. The Westergaard 2006 trial had two acupuncture treatment arms, one arm received two sessions and
the other arm received three, and these arms were grouped separately for this subgroup analysis. †Incomplete outcome data were also prespecified as
a methodological subgroup variable, but no trial had a high risk of bias due to incomplete outcome data for the clinical pregnancy outcome. ‡Only the
Craig et al. trial was judged to have a co-intervention that was applied unequally across treatment group. Namely, in this trial, which evaluated off-site acu-
puncture, patients in the acupuncture group only were required to drive to and from the off-site acupuncturist’s office both before and after the embryo
transfer procedure.















spontaneous abortion rates as losses between clinical pregnancy and
ongoing pregnancy (across all trials, RR ¼ 1.01; 95% CI, 0.76–1.35;
I2 ¼ 0%; 11 trials). A total of seven trials (Dieterle et al., 2006; Smith
et al., 2006; Craig et al., 2007; So et al., 2009, 2010; Omodei et al.,
2010; Moy et al., 2011) included descriptions of other adverse events,
but none of these trials reported any serious adverse events associated
with acupuncture.
Discussion
Summary of main results
We found no statistically significant pooled benefits of one to three ses-
sions of acupuncture adjuvant to IVF, across all trials, or when restricting
to sham-controlled or no adjuvant treatment-controlled trials.
However, there was substantial (Deeks et al., 2011) heterogeneity.
Of the 11 variables prespecified for subgroup analyses, only the baseline
pregnancy rate variable showed a statistically significant subgroup effect
and appeared to explain most of the heterogeneity in the results for the
primary outcome measure (clinical pregnancy).
Subgroup analyses based on clinical
characteristics
Baseline pregnancy rate was the only statistically significant subgroup
finding in our previous review on this topic (Manheimer et al., 2008)
and this has been confirmed in this review update. The magnitude of
this subgroup effect is large and there is a low likelihood that chance
explains this apparent subgroup effect. In addition, this subgroup effect
does not appear to be due to an association between baseline pregnancy
rate and either blinding- or randomization-related covariates, or any of
the other prespecified covariates.
The reasons for differences in baseline (i.e. control group) pregnancy
rates across trials are complex and driven by several factors, although
these differences may be largely explained by differences in IVF regula-
tions across countries, in particular, regarding the number of embryos
transferred per cycle (Ludwig et al., 2000; Dal Canto et al., 2006;
Abdalla, 2010; Maheshwari et al., 2011). That is, European countries
have lower IVF pregnancy rates than does the USA, and a major
Figure 3 Meta-regression with baseline clinical pregnancy rate as
single continuous covariate. Outcome was RR of clinical pregnancy.
Circle size represents weight each study was given in the
meta-regression analysis. For this meta-regression, the adjusted
R2 ¼ 90% and the I2resid = 3.3%.
Figure 4 Funnel plot of trials meeting inclusion criteria. The intervention effect estimated from individual trials is plotted on the horizontal scale and a
measure of the standard error of the intervention effect is plotted on the vertical axis. The control groupsuccess rate is included foreach trial on the plot. The
Egger test P-value for funnel plot asymmetry is 0.032.















reason for this difference is that fewer embryos are transferred per cycle
in European countries than in the USA (Maheshwari et al., 2011), in an
effort to reduce twins and triplets (Abdalla, 2010). In Italy and
Germany, the country setting of six of the eight included European
RCTs, the average IVF pregnancy rates are lower than in other European
countries because of Italian/German laws which set a limit of using only
three ooctyes per IVF cycle, all of which must be transferred, regardless
of whether these oocytes develop into high-quality embryos (Ludwig
et al., 2000; Gerris, 2005; Dal Canto et al., 2006; Maheshwari et al.,
2011). In the USA, on the other hand, embryo selection (Alpha Scientists
in Reproductive Medicine and ESHRE Special Interest Group of
Embryology, 2011) is routine and the number of embryos that can be
transferred is less strict and less well-regulated (Abdalla, 2010).
Another reason for higher baseline pregnancy rates in the USA is that
US patients with poor ovarian reserve (i.e. those who produce fewer
oocytes and end up with fewer embryos to transfer or chose from) are
more likely to be diverted from undergoing IVF (Abdalla, 2010). Differ-
ences in baseline pregnancy rates can also be due to differences in inclu-
sion criteria across trials. For example, one Italian trial in this review
(Arnoldi et al., 2010) restricted trial inclusion to women with an un-
favourable reproductive prognosis, which might explain why the baseline
pregnancy rates in this Italian trial were lower than Italian national
averages (Nygren et al., 2011). Two German trials (Paulus et al., 2002,
2003) restricted trial inclusion to only women with high-quality
embryos available to transfer, which might explain why the baseline preg-
nancy rates in these German trials were higher than German national
averages (Nygren et al., 2011). Finally, differences in baseline pregnancy
rates across included trials can also be due to participant selection in the
individual trials, in terms of participants’ predictors for success in IVF
(van Loendersloot et al., 2010). Namely, for two of the trials with
lower baseline pregnancy rates (Dieterle et al., 2006; Smith et al.,
2006), the trial authors reported that the trials’ baseline pregnancy
rates were lower than the average pregnancy rates at the trials’ clinics
because of the higher mean age of the participants included in the trials
relative to the mean age of patients seen at the clinic site. And for one
of these two trials (Smith et al., 2006), the trial authors also reported
an overrepresentation by women with poor pregnancy outcomes
from previous cycles. Thus, there are multiple factors that can explain
differences across trials in baseline pregnancy rates. One potential
explanation for the differential effect of acupuncture in trials with
higher versus lower baseline rates may be that in IVF settings where
the baseline pregnancy rates are already high, the relative added value
of additional co-interventions, such as acupuncture, may be lower
(Sherman et al., 2009).
Figure 5 Effects of acupuncture on spontaneous abortion outcome. The centres of the squares represent estimates from individual trials, the centres of
the quadrilaterals represent pooled estimates, and the horizontal lines represent 95% CIs.















Although it was not a statistically significant subgroup finding, there
was a trend suggesting that acupuncture administered on-site of the
IVF clinic had more positive effects than acupuncture administered
off-site of the IVF clinic. However, inferences regarding this observed dif-
ferential effect areweakbecause onlya single trial (Craiget al., 2007) con-
tributes to the off-site subgroup. The qualitatively and quantitatively
different results in the off-site Craig et al. trial, which had very high base-
line pregnancy rates (i.e. 67%), could have been driven by another vari-
able, other than the off-site acupuncture administration. One potential
biological rationale for the negative results of the Craig et al. trial, postu-
lated by the trial’s principal investigator (Sullivan, 2007), is that the
co-intervention, in only the acupuncture group, of driving to and from
the off-site acupuncturist’s office, both before and after the embryo
transfer, rather than resting in bed, may have increased patients’
stress, which may have affected pregnancy success rates negatively
through a psychobiological effect mechanism (Ferin and Vande Wiele,
1984; Stener-Victorin et al., 1996; Matthiesen et al., 2011). However,
studies of the effects of stress on IVF success rates have had inconsistent
results, and the influence of psychological stress on IVF success appears
limited, at best (Matthiesen et al., 2011). In addition, while resting in bed
for 2 or 3 days after the embryo transfer procedure has been recom-
mended by some IVF physicians on the theory that bed rest can
prevent the embryo from being expelled from the uterus, there is no evi-
dence to support this recommendation (Li et al., 2011). Thus, the
support from a biological rationale for this putative subgroup effect
regarding on- versus off-site acupuncture is unconvincing. However,
because only a single trial has evaluated off-site acupuncture, and
because Craig et al. conducted this trial specifically to address whether
the positive findings from the earlier Paulus et al. (2002, 2003) trials,
which involved on-site acupuncture could be confirmed in ‘real world’
off-site settings (Sullivan, 2007), and because this Craig et al. trial found
a reduction in pregnancy rates with off-site adjuvant acupuncture com-
pared with no IVF adjuvant treatment, IVF physicians and patients may
wish to consider this trial’s findings in deciding whether IVF patients
should have off-site acupuncture on the day of embryo transfer.
Subgroup analyses based on risk of bias
Seven of the trials (Paulus et al., 2003; Dieterle et al., 2006; Smith et al.,
2006; So et al., 2009, 2010; Andersen et al., 2010; Moyet al., 2011) used a
sham control to blind participants. However, the necessity to blind par-
ticipants is arguable when the outcomes are entirely objective (that is,
pregnancy and birth) (Hrobjartsson and Gotzsche, 2004; Kaptchuk
et al., 2006; Manheimer et al., 2008; Wood et al., 2008). Indeed, the
Cochrane Menstrual Disorders and Subfertility Group website states
that ‘a study may not be blinded but if follow-up is complete and out-
comes are unequivocal the lack of blinding may be assessed not to in-
crease risk of bias’ (Cochrane Menstrual Disorders and Subfertility
Group, 2010). As previously argued (Manheimer et al., 2008;
Manheimer, 2011), it seems unlikely that a woman’s knowledge of
whether or not she was receiving acupuncture would affect her ability
to become pregnant. Even if adjuvant acupuncture were to increase
IVF success rates strictly through a non-needling-related psychobiologic-
al placebo effect mechanism (i.e. women who believe they are receiving
acupuncture have reduced stress, which thereby subtly influences their
pregnancy-related hormone production), this effect would be integral
to the working mechanism by which adjuvant acupuncture increases
IVF pregnancy success rates. Therefore, it seems inappropriate to
control for and equalize any such stress-reduction placebo effect by
using a sham control to blind trial participants, unless the purpose of
the trial is to study the mechanism responsible foradjuvant acupuncture’s
effects on IVF success rates.
The risk of using a sham control is that some sham interventions may
influence the pregnancy outcome through the same putative mechanism
of true acupuncture (e.g. by needle insertion, stimulation of true acu-
puncture points; Manheimer, 2011). For example, the sham interven-
tion used in four of the sham-controlled trials (Paulus et al., 2003;
So et al., 2009, 2010; Andersen et al., 2010) was the non-penetrating
Streitberger sham needles placed at the true acupuncture points. The
two validation trials (Streitberger and Kleinhenz, 1998; White et al.,
2003) of this Streitberger sham needle found that these Streitberger
sham needles elicit the de qi needling sensation in a large proportion
of patients, suggesting that these sham needles may have acupuncture-
specific needling effects, particularly if the Streitberger sham needles are
manipulated in the same way as the true acupuncture needles, as was
the case in two of the included sham-controlled trials (So et al., 2009,
2010). We initially attempted to assess whether or not the sham
control intervention used in each trial was likely to have a risk of affecting
the pregnancy outcome through the same putative mechanism of true
acupuncture; however, because no consensus could be reached in
making these assessments, the assessments could not be used in the
analyses. Instead, our subgroup analysis test involved grouping all sham-
controlled trials together in a single subgroup; however, some sham
control interventions may be physiologically active, and others physiolo-
gically inert, in terms of their effects on the pregnancy outcome, and
therefore this subgroup test (i.e. no adjuvant treatment versus any
type of sham control) may not detect an important effect of control
type. Finally, although this review found no statistically significant sub-
group effect for the type of control, the no adjuvant treatment-
controlled subgroup showed a slightly larger pooled effect than the
sham-controlled subgroup, particularly if the outlying Craig et al. trial
was removed [RR 1.31 (1.08–1.58); I2 ¼ 49%; 8 trials]. Therefore,
the possibility that some of the sham interventions may have had
acupuncture-specific effects cannot be ruled out.
Although it was not a statistically significant subgroup finding, there
was a trend suggesting that IVF physicians who are not blinded may
perform more successful embryo transfers when adjuvant acupunc-
ture is used, at least in a trial setting. This subgroup finding was unex-
pected because, considering the cost of embryo transfer and the
importance of successful transfers to maintaining high pregnancy
success rates at clinics, we a priori expected that physicians would
be motivated primarily to perform a successful embryo transfer for
all trial participants, rather than to show that acupuncture, a non-
proprietary treatment, is an effective adjuvant procedure. Indeed, in
IVF trials, where outcomes are objective, blinding of either patients
or physicians is ‘infrequently attempted’ (Arce et al., 2005), and
such blinding components are often not considered as critical ele-
ments related to the evaluation of risk of bias (Vail and Gardener,
2003; Dias et al., 2006). Yet, this borderline significant subgroup
finding suggests that physician blinding may decrease bias, and there-
fore this variable may possibly be appropriate for inclusion in scales
that assess risk of bias of IVF trials. However, blinding the embryo
transfer physician still does not require the use of a sham acupuncture
control (Paulus et al., 2002; Craig et al., 2007; Domar et al., 2009;















Madaschi et al., 2010) because the adjuvant acupuncture is not admi-
nistered at the same time as the embryo transfer procedure.
Interpretation of small study effects
The funnel plot indicated that estimates of the intervention effect were
more beneficial in smaller studies, which may be due to smaller studies
with statistically significant, positive results being more likely to be pub-
lished (i.e. publication bias). Funnel plot asymmetry can also be due to
other types of reporting bias besides publication bias (e.g. language
bias, multiple publication bias, publication of negative results only as con-
ference abstracts). However, in this review, these other types of report-
ing bias seem less likely than publication bias, given our extensive
searches (including Chinese databases and conference proceedings),
and our contacts with the authors of included trials, which confirmed
that none of these trials are duplicate publications. Although we
attempted to locate any unpublished trials by contacting experts in the
field, none were located, and the possibility of unidentified, unpublished
studies with negative results is one possible explanation for the asymmet-
ric funnel plot. However, the Cochrane Collaboration’s guidelines for
addressing reporting biases and interpreting funnel plot asymmetry
stress that ‘an asymmetric funnel plot should not be equated with publi-
cation bias’, and that ‘publication bias should be consideredas onlyone of
a number of possible explanations’ (Sterne et al., 2011). Also according
to Cochrane guidelines, ‘Funnel plot asymmetry . . . may also result from
clinical heterogeneity between studies (for example different control
event rates) . . . ’ (Alderson and Green, 2002). We therefore added
the control event rates to the funnel plot, and the resulting plot shows
that the trials with the lowest control group success rates show the
most positive results (Fig. 4). Therefore, it is impossible to know
whether the funnel plot asymmetry is due to publication bias, or
whether this pattern is due to greater benefits in the trials with lower
control group success rates (Alderson and Green, 2002).
We also tried to identify other potential explanations for the funnel
plot asymmetry. Namely, we prepared separate funnel plots (and con-
ducted corresponding separate Egger tests) for the sham-controlled
trial subgroup and the no adjuvant treatment-controlled trial subgroup.
These separate tests found that the funnel plot asymmetry seemed to be
driven largely by the sham-controlled trials (Egger P ¼ 0.028 for sham-
controlled trials and P ¼ 0.303 for no adjuvant treatment-controlled
trials). Cochrane guidelines suggest that funnel plot asymmetry may be
due to larger ‘negative’ trials (conducted later to confirm the earlier ‘posi-
tive’ trials’ results) using a more effective control treatment or a less thor-
oughly implemented test intervention (Sterne et al., 2011). Therefore,
this issue was examined among the sham-controlled trials that contribu-
ted to the funnel plot asymmetry. Namely, three of the largest sham-
controlled trials (So et al., 2009, 2010; Andersen et al., 2010), which all
had ‘negative’ results, used non-penetrating Streitberger sham needles
placed at the true acupuncture points as the control intervention.
For two of these trials (So et al., 2009, 2010), these sham needles
were manipulated in the same way as the true acupuncture needles.
The author of these two trials discussed that this sham control interven-
tion used was likely an effective treatment due to its acupuncture-
specific effects, and a conclusion of their 2009 trial was that ‘Placebo
acupuncture may not be inert’ (So et al., 2009). For the third and
largest trial (Andersen et al., 2010), for which the acupuncture was per-
formed by nurse-acupuncturists and other nurses trained by these nurse-
acupuncturists, the true acupuncture needles were not manipulated, in
order to avoid unblinding the patients to treatment assignment. There-
fore, in these three recent, large sham-controlled trials with ‘negative’
results, manipulating the needles in the sham acupuncture group (So
et al., 2009, 2010) and/or not manipulating the needles in the true acu-
puncture group (Andersen et al., 2010) may have caused the control
treatment to be an effective treatment and/or the test intervention to
be less effective. This possibility is particularly relevant in light of a
recent trial which found that manipulating the acupuncture needles to
obtain the ‘de qi’ sensation resulted in a much greater therapeutic
effect compared with not manipulating the needles (odds ratio ¼ 4.16,
for primary outcome; Xu et al., 2013). The use of a potentially more ef-
fective control and/or less thoroughly implemented test intervention in
these three large sham-controlled trials with ‘negative’ results is only one
of many possible explanations for the funnel plot asymmetry among the
sham-controlled trials. This example is provided primarily to illustrate the
challenges in interpreting funnel plot asymmetry in meta-analyses of
complex interventions that used heterogeneous treatments and con-
trols, when the funnel plot test was devised on the premise that the
studies come from a single underlying population (Terrin et al., 2003;
Sterne et al., 2011).
Comparison with other studies or reviews
Although there have been multiple systematic reviews of acupuncture as
an adjuvant to IVF (Cheong et al., 2008, 2010; El-Toukhy et al., 2008;
Manheimer et al., 2008; Ng et al., 2008; El-Toukhy and Khalaf, 2009;
Sunkara et al., 2009; Qu et al., 2012; Zheng et al., 2012a), only the
2012 reviews by Zheng et al. (2012a) and Qu et al. (2012) included
some of the more recent trials. And therefore, comparisons with the
Zheng et al. review and Qu et al. review are most relevant. The Zheng
et al. review concluded that adjuvant acupuncture improves clinical preg-
nancy rates and live birth rates, but only after excluding the Streitberger
sham needle-controlled trials. Zheng et al. excluded these trials in
drawing their conclusions because they contended that the Streitberger
sham intervention is not an inert control; however, Zheng et al. did not
provide evidence to support this contention. Also, because the Zheng
et al. review was not based on a publicly available protocol, it cannot
be determined whether the decision to exclude the trials using the Streit-
berger shams was prespecified, or whether instead this exclusion was
driven by the Streitberger sham-controlled trials’ results. In addition,
the Zheng et al. review, as well as all other previous systematic
reviews, were based on only the published data, with the exception of
one previous review (El-Toukhy et al., 2008) for which two RCT
authors (Craig et al., 2007; Domar et al., 2009) were contacted and sup-
plied additional information. We have successfully obtained unpublished
data on methods and/or outcomes from authors of all eligible RCTs,
which allowed for the inclusion of more RCTs and more complete infor-
mation from these included RCTs. For example, Zheng et al., excluded
two methodologically sound RCTs (Omodei et al., 2010; Moy et al.,
2011) because the ‘data for the exact pregnancy events and totals
were not available’ from the publication; however, we were able to
obtain precise outcome data for these two RCTs by contacting the
authors. Finally, Zheng et al., included both the early results from one
trial (Benson et al., 2006), as well as the final results (Fratterelli et al.,
2008), thus double counting some of the same participants from this















trial. The other 2012 review, by Qu et al., concluded that no benefits of
adjuvant acupuncture were apparent from the effect estimate pooled
from all trials. However, the Qu et al. review did not include six of the
RCTs included in our review (Fratterelli et al., 2008; Arnoldi et al.,
2010; Madaschi et al., 2010; Omodei et al., 2010; So et al., 2010; Feliciani
et al., 2011), four of which (Fratterelli et al., 2008; Arnoldi et al., 2010;
Omodei et al., 2010; So et al., 2010) were published prior to October
2010, the end date of Qu et al.’s search window. Also, Qu et al. did
not examine potential subgroup variables to understand their impact
on the effects of adjuvant acupuncture on IVF, on the clinically and meth-
odologically heterogeneous trials reviewed. In contrast, the detailed in-
formation we obtained allowed us not only to evaluate potential effect
modification due to the prespecified subgroup variables, but also to
examine whether other subgroup variables were confounders of any ap-
parent subgroup effects.
Implications for research
Future studies might further investigate the relationship between base-
line rate of pregnancy and the efficacy of adjuvant acupuncture, and
also further investigate which variables are responsible for this relation-
ship. Because baseline pregnancy rate is possibly a proxy for the
number of embryos transferred, although other factors are also involved
(Abdalla, 2010), an individual patient data meta-analysis (Broeze et al.,
2010) may be helpful to further investigate the relationship between
the number of embryos transferred, as well as other individual participant
level variables (e.g. age (Westergaard et al., 2006)), and the efficacy of
adjuvant acupuncture.
For future trials, if the objective is to investigate the mechanism of
IVF adjuvant acupuncture, and specifically whether any effect is
mediated through the point-specific needle placement, or alternatively
through a non-needling-related psychobiological placebo mechanism,
both a sham control arm and a no adjuvant treatment arm would
be necessary. A sham control arm might also be necessary for recruit-
ment, if potential trial participants would be unwilling to be rando-
mized to a no adjuvant treatment control (Smith et al., 2012).
However, because it is difficult to assess whether or not a sham
control intervention has acupuncture-specific effects that may increase
IVF success rates, sham-controlled trials in this area can also potential-
ly complicate the interpretation of the overall evidence (Manheimer,
2011). For addressing the more clinically relevant question of the
total effects of acupuncture (i.e. specific needling effects plus any
non-needle-related placebo effects) in contributing to any increases
in IVF pregnancy success rates, a sham control seems unnecessary
(Manheimer, 2011). This question about the need for sham controls
may also apply to other invasive, difficult to blind adjuvant procedures
evaluated in IVF RCTs (Holt et al., 2009).
Data availability
All our study data, including full details of the characteristics of each
included RCT and all outcome data extracted from each included
RCT, is included in a RevMan file, which will be made available to
researchers upon request, for reproducing these results.
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Supplementary data are available at http://humupd.oxfordjournals.org/.
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